ZyVersa Therapeutics (ZVSA) Earnings Per Share (EPS)

Price: $0.69
Market Cap: $2.50M
Avg Volume: 2.32M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.68
52W Range: $0.552-6.7
Website: ZyVersa Therapeutics
Earnings Per Share (EPS) Summary (Annual)

According to ZyVersa Therapeutics's latest annual financial reports, the company has an earnings per share (EPS) of $-848.03 and a diluted EPS of $-848.03. The EPS indicates the portion of a company's profit allocated to each outstanding share of common stock, serving as an indicator of a company's profitability.

The company's EPS growth rate stands at 22.18%, and the diluted EPS growth rate is 22.18%. These metrics reflect the annual growth rate of earnings per share and diluted earnings per share over the specified period.

EPS

$-848.03

Diluted EPS

$-848.03

EPS Growth

22.18%

ZyVersa Therapeutics Historical EPS
$0.00$0.00$-200.00$-200.00$-400.00$-400.00$-600.00$-600.00$-800.00$-800.00$-1000.00$-1000.00$-1200.00$-1200.00EPS20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '24
ZyVersa Therapeutics Historical EPS Growth
100.00%100.00%0.00%0.00%-100.00%-100.00%-200.00%-200.00%-300.00%-300.00%-400.00%-400.00%-500.00%-500.00%EPS Growth20212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '24
EPS History

The table below shows the EPS for each year, with the latest data available for the last fiscal year 2024.

Year EPS Change
2024 $-848.03 22.18%
2023 $-1089.67 -17.14%
2022 $-930.251 -435.69%
2021 $-173.656 36.26%
2020 $-272.447 0.00%

Related Metrics

Explore detailed financial metrics and analysis for ZVSA.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio